Financhill
Back

Equity Residential Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
51

EQR
Equity Residential

Last Price:
69.98
Seasonality Move:
-0.79%
Sell
48

SRPT
Sarepta Therapeutics

Last Price:
146.03
Seasonality Move:
26.84%
Buy
51
Equity Residential (EQR) is a Buy

Is Equity Residential a Buy, Sell or Hold?

  • The current Equity Residential [EQR] share price is $70.86. The Score for EQR is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • EQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $147.64. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EQR Stock Price Chart

What is Equity Residential's stock price today?

  • The Equity Residential share price today is $70.86
    The current trend is moderately bullish and EQR is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $147.64
    The current trend is moderately bearish and SRPT is experiencing slight buying pressure.

EQR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.94 Buy
Relative Strength Index (14 RSI): 69.5 Buy
Chaikin Money Flow: -258737 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (67.47 - 69.61) Buy
Bollinger Bands (100): (62.35 - 67.83) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.57 Buy
Relative Strength Index (14 RSI): 53.76 Buy
Chaikin Money Flow: 161918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (136.76 - 160.52) Sell
Bollinger Bands (100): (118.69 - 143.69) Buy

EQR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.49 Buy
20-day SMA: 68.67 Buy
50-day SMA: 67.22 Buy
200-day SMA: 61.92 Buy
8-day EMA: 69.82 Buy
20-day EMA: 68.79 Buy
50-day EMA: 67.29 Buy
200-day EMA: 64.01 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 148 Sell
20-day SMA: 151.68 Sell
50-day SMA: 136.96 Buy
200-day SMA: 118.27 Buy
8-day EMA: 147.68 Sell
20-day EMA: 146.93 Buy
50-day EMA: 140.13 Buy
200-day EMA: 125.64 Buy

Equity Residential Earnings Growth & EQR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.05 per share, and an increase next year of $0.19 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.

Equity Residential Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):